Which of the following drug has visual field defects as an adverse effect?
Pegvisomant is GH receptor antagonist Known to cause visual field defect. Pegvisomant given subcutaneously cause toxicity:increase liver enzymes Also known as somatotropin antagonist Bromocriptine and Cabergoline are D2 receptor agonists Leuprolide is GnRH agonist
Cabergoline
Bromocriptine
Pegvisomant
Leuprolide
Pituitary-Hypothalmic System and Thyroid